TrianglePUBLICATIONS · 14976046
Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2004 Jun 15
- First author
- Ghielmini M
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Ghielmini M
- type
- Author
- name
- Schmitz SF
- type
- Author
- name
- Cogliatti SB
- type
- Author
- name
- Pichert G
- type
- Author
- name
- Hummerjohann J
- type
- Author
- name
- Waltzer U
- type
- Author
- name
- Fey MF
- type
- Author
- name
- Betticher DC
- type
- Author
- name
- Martinelli G
- type
- Author
- name
- Peccatori F
- type
- Author
- name
- Hess U
- type
- Author
- name
- Zucca E
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Ghielmini M
- type
- Author
- name
- Schmitz SF
- type
- Author
- name
- Cogliatti SB
- type
- Author
- name
- Pichert G
- type
- Author
- name
- Hummerjohann J
- type
- Author
- name
- Waltzer U
- type
- Author
- name
- Fey MF
- type
- Author
- name
- Betticher DC
- type
- Author
- name
- Martinelli G
- type
- Author
- name
- Peccatori F
- type
- Author
- name
- Hess U
- type
- Author
- name
- Zucca E
- type
- Author
- bibliography ids
- nci-bib-cff079d33f381828fd15e66b
- book metadata
- content sha256
- 011283322fbac61b123c62806727bc95403d49dd7d25ae926cc230de61cb9024
- document type
- citation
- dois
- 10.1182/blood-2003-10-3411
- electronic publication date
- display
- 2004 Feb 19
- precision
- day
- year
- 2004
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:14976046
- immutable id
- pubmed:14976046@011283322fbac61b123c62806727bc95403d49dd7d25ae926cc230de61cb9024
- journal
- abbreviation
- Blood
- issn electronic
- Source null
- issn print
- 0006-4971
- issue
- 12
- name
- Blood
- nlm unique id
- 7603509
- pages
- 4416-23
- volume
- 103
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 14976046
- provenance
- batch id
- aee154f17d1b0501fe1f
- provider
- NCBI PubMed ESummary
- record sha256
- f960f8b7e682abda0f6f6ee2e521f042435632ce391fb0e85ef59274a6072211
- response sha256
- 75a826407a9022d376294c7400982e19a458458cea55b2628fd3fddd75bc0f08
- retrieved at
- 2026-09-09T23:45:53.270896+00:00
- publication date
- display
- 2004 Jun 15
- precision
- day
- year
- 2004
- publication types
- Clinical Trial
- Comparative Study
- Controlled Clinical Trial
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule.
Preserved source evidence · Independent clinical review pending · Not medical advice